These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 17201279)
1. [The pharmacoepidemiology of drugs used in treatment of patients with chronic obstructive pulmonary disease]. Tarasenko IV; Svetyĭ LI Klin Med (Mosk); 2006; 84(10):65-7. PubMed ID: 17201279 [TBL] [Abstract][Full Text] [Related]
2. [Peculiarities of pharmacotherapy in patients with chronic heart failure]. Lopukhova VA; Svetyĭ LI; Gerasimov VB Klin Med (Mosk); 2006; 84(10):63-4. PubMed ID: 17201278 [TBL] [Abstract][Full Text] [Related]
3. [Possibilities of improving the diagnosis and treatment of obstructive pulmonary diseases in the Northern Administrative District of Moscow]. Shmeleva NM; Galkin IV; Sidorova VP; Belevskiĭ AS; Shmelev EI Probl Tuberk Bolezn Legk; 2008; (7):18-22. PubMed ID: 19110766 [TBL] [Abstract][Full Text] [Related]
4. [Epidemiology of chronic obstructive pulmonary diseases]. Voinov AIu; Lobanov AA Med Tr Prom Ekol; 2003; (4):23-5. PubMed ID: 12872459 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. Le Jemtel TH; Padeletti M; Jelic S J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727 [TBL] [Abstract][Full Text] [Related]
8. The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based study. Hansen JG; Pedersen L; Overvad K; Omland Ø; Jensen HK; Sørensen HT COPD; 2008 Dec; 5(6):347-52. PubMed ID: 19353348 [TBL] [Abstract][Full Text] [Related]
9. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388 [TBL] [Abstract][Full Text] [Related]
11. Asthma and COPD: definitions, epidemiology, and treatment guidelines. Berger WE; Cline DC Postgrad Med; 2005 Dec; 118(6 Suppl Acute):2-8. PubMed ID: 19667710 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P Am J Respir Crit Care Med; 2007 Oct; 176(8):753-60. PubMed ID: 17575095 [TBL] [Abstract][Full Text] [Related]
13. [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study]. Geldmacher H; Biller H; Herbst A; Urbanski K; Allison M; Buist AS; Hohlfeld JM; Welte T Dtsch Med Wochenschr; 2008 Dec; 133(50):2609-14. PubMed ID: 19052996 [TBL] [Abstract][Full Text] [Related]
14. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)]. Gillissen A; Gessner C; Hoheisel G; Juergens U Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787 [TBL] [Abstract][Full Text] [Related]
15. [The overlap syndrome: obstructive sleep apnea and chronic obstructive pulmonary disease]. Shteinberg M; Weiler-Ravel D; Adir Y Harefuah; 2009 May; 148(5):333-6, 348. PubMed ID: 19630366 [TBL] [Abstract][Full Text] [Related]
16. [Comorbidity in chronic obstructive pulmonary disease]. Karoli NA; Orlova EE; Markova AV; Rebrov AP Ter Arkh; 2008; 80(3):20-3. PubMed ID: 18441678 [TBL] [Abstract][Full Text] [Related]
17. [Future therapies for chronic obstructive pulmonary disease]. Barnes PJ Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2884-6. PubMed ID: 17288781 [No Abstract] [Full Text] [Related]
18. Dispensed volumes of anti-asthmatic drugs related to the prevalence of asthma and COPD in Sweden. Haupt D; Wettermark B; Nilsson JL Pharmacoepidemiol Drug Saf; 2008 May; 17(5):461-7. PubMed ID: 18302301 [TBL] [Abstract][Full Text] [Related]
19. [Associations of chronic obstructive pulmonary disease, bronchial asthma, and type 1 diabetes mellitus]. Kobylianskiĭ VI; Babadzhanova GIu; Suntsov IuI Klin Med (Mosk); 2009; 87(9):36-8. PubMed ID: 19882878 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and outcome of severe chronic obstructive pulmonary disease exacerbations caused by multidrug-resistant bacteria. Nseir S; Ader F Curr Opin Pulm Med; 2008 Mar; 14(2):95-100. PubMed ID: 18303416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]